Quest Diagnostics Reports Third Quarter 2022 Financial Results; Raises Guidance for Full Year 2022

Go back to Quest Diagnostics Reports Third Quarter 2022 Financial Results; Raises Guidance for Full Year 2022
Quest Diagnostics (NYSE: DGX) Delayed: 245.17 -1.28 (0.52%)
Previous Close $246.45    52 Week High $86.85 
Open $247.13    52 Week Low $59.66 
Day High $248.84    P/E 46.17 
Day Low $244.84    EPS $5.31 
Volume 263,550